|
|
SPOT ON
|
|
Candesartan (e.g. ATACAND) in heart failure? |
|
Perindopril (COVERSUM) in coronary heart disease? |
|
|
NEW ON THE MARKET
|
|
Not at all new: Escitalopram (CIPRALEX) |
|
|
TREATMENT RECOMMENDATION
|
|
Long-term anticoagulation in idiopathic venous thromboembolism
|
|
|
QUALITY ASSESSMENT
|
|
Hydrochlorothiazide and paracetamol preparations
|
|
|
a-t READERS' QUESTIONS AND COMMENTS
|
|
GUKOKINE for diabetes?
Old registered drugs and what happens then
Proton pump inhibitor via PEG tube?
Expired drugs
ISCOVER/PLAVIX more expensive
|
|
|
IN BRIEF
|
|
Beware of "drug holidays" in patients with multidrug-resistant HI virus
High-dose dexamethasone (e.g. FORTECORTIN) therapy for idiopathic thrombopenia?
Chronic myeloid leukaemia: Survival with imatinib (GLIVEC)
Hot flushes: Phytoestrogens from red clover vs placebo
|
|
|
CURRENT ADR NETWORK REPORT
|
|
Granulomas after intradermal injection of DERMALIVE
|
|
|
SIDE EFFECTS
|
|
Bicalutamide (CASODEX) in patients with localized prostate cancer
Sibutramin (REDUCTIL): Market withdrawal warranted
|
|